Alveolar Soft-Part Sarcoma Treatment with Interferon Alpha-2b
Author Information
Author(s): Roozendaal K J, de Valk B, ten Velden J J A, van der Woude H J, Kroon B B R
Primary Institution: Onze Lieve Vrouwe Gasthuis
Hypothesis
Can interferon alpha-2b effectively treat chemoresistant alveolar soft-part sarcoma?
Conclusion
The treatment with interferon alpha-2b resulted in a good partial response in a patient with chemoresistant alveolar soft-part sarcoma.
Supporting Evidence
- The patient had a fast-growing tumor in her calf.
- After chemotherapy failed, interferon alpha-2b was started.
- The treatment led to a good partial regression of the tumor and lung metastases.
- The patient experienced an acute psychotic syndrome as a side effect of the treatment.
Takeaway
A 24-year-old woman with a rare cancer got better after taking a medicine called interferon alpha-2b, even though other treatments didn't work.
Methodology
The patient was treated with interferon alpha-2b after failing multiple chemotherapy regimens.
Limitations
The treatment had to be stopped due to side effects, and the long-term efficacy of interferon alpha-2b in ASPS is still uncertain.
Participant Demographics
One 24-year-old female patient with chemoresistant ASPS.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website